marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Salarius Pharmaceuticals Financial Ratios 2011-2024 | SLRX
Annual Financial Ratios Salarius Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -0.1 | -0.1 | -2.7 | -1.2 | -0.3 | -2.1 | -1.8 | -4.0 | -33.1 | - | - | - |
P/S |
- | - | 0.4 | 3.8 | 2.5 | 6.6 | 56.7 | 71.5 | - | - | - | - | - |
EPS |
-3.8 | -14.9 | -7.7 | -0.5 | -2.1 | -1.2 | -2.0 | -2.4 | -2.1 | -4.6 | - | - | - |
EV (Enterprise Value) |
-2.58 M | -3.44 M | -26.3 M | 11.6 M | 8.24 M | -3.17 M | 59 M | 53.7 M | 52.9 M | 8.3 M | - | - | - |
EBITDA per Share |
-3.95 | -15 | -7.73 | -0.408 | -2.49 | -30.3 | -49.8 | -61 | -52 | - | - | - | - |
EV/EBITDA |
2.1 | -1.3 | -0.7 | 0.2 | -1.5 | -1.3 | -1.7 | -29.0 | - | - | - | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.03 | -0.01 | -0.01 | -0.12 | 0.11 | 0.32 | 1.09 | - | - | - |
P/B |
0.4 | 0.4 | 0.0 | 0.9 | 0.8 | 0.6 | 2.5 | 1.2 | 1.3 | 7.7 | - | - | - |
P/CF |
-0.2 | -0.2 | -0.1 | -1.9 | -0.7 | -0.2 | -2.6 | -2.2 | -5.6 | -40.5 | - | - | - |
ROE % |
-237.22 | -304.37 | -32.97 | -33.18 | -65.55 | -236.16 | -118.30 | -66.58 | -31.61 | -23.22 | - | - | - |
ROA % |
-190.43 | -215.74 | -31.27 | -29.49 | -49.92 | -211.00 | -98.40 | -62.47 | -30.65 | -22.49 | - | - | - |
ROCE % |
-243.89 | -306.62 | -33.09 | -31.86 | -78.11 | -237.80 | -119.15 | -67.23 | -31.68 | -23.19 | - | - | - |
Current Ratio |
5.1 | 3.4 | 19.3 | 8.5 | 1.4 | 9.3 | 5.9 | 16.1 | 32.4 | 32.1 | - | - | - |
DSO |
- | - | 382.4 | - | - | 4.3 | 3.0 | 4.4 | - | - | - | - | - |
DIO |
- | - | - | - | - | 158.4 | 311.2 | 250.1 | - | - | - | - | - |
DPO |
- | - | - | - | - | 290.2 | 1444.4 | 656.6 | - | - | - | - | - |
Operating Cycle |
- | - | 382.4 | - | - | 162.7 | 314.2 | 254.5 | - | - | - | - | - |
Cash Conversion Cycle |
- | - | 382.4 | - | - | -127.5 | -1130.2 | -402.1 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Salarius Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.76 | -2.37 | -0.41 | - | -5.21 | -11.45 | -2.23 | - | -6.41 | -2.2 | -3.3 | - | -2.09 | -0.07 | -0.06 | - | -0.1 | -0.13 | -0.22 | - | -0.73 | -0.3 | -0.64 | -0.11 | -0.2 | -0.5 | -0.46 | -0.46 | -0.54 | -0.51 | -0.49 | -0.48 | -0.65 | -0.71 | -0.61 | -0.51 | -0.53 | -0.47 | -0.59 | -1.82 | -1.11 | -1.42 | -0.07 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.42 | - | - | - | -2.27 | - | -6.44 | -2.22 | -3.3 | - | -2.08 | -0.07 | -0.06 | - | -0.1 | -0.14 | -0.25 | - | -1.01 | -0.26 | -0.6 | -0.11 | -0.18 | -0.5 | -0.46 | -0.46 | -0.53 | -0.51 | -0.49 | -0.48 | -0.65 | -0.71 | -0.61 | - | -0.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-180.36 | -187.27 | -173.39 | -182.31 | -269.05 | -315.64 | -284.83 | -120.30 | -129.06 | -51.08 | -42.51 | -19.26 | -27.01 | -26.00 | -27.34 | -25.20 | -50.04 | -67.13 | -67.61 | -47.76 | 110.27 | 159.29 | 169.03 | 179.31 | 298.08 | 241.83 | 210.38 | 186.08 | -104.04 | -89.91 | -78.82 | -66.58 | -61.82 | -52.73 | -41.25 | -31.61 | 34.18 | 73.41 | 114.58 | 122.52 | 65.29 | 34.91 | 1.42 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-129.46 | -133.34 | -125.42 | -114.34 | -187.40 | -231.40 | -216.44 | -107.47 | -115.91 | -34.09 | -40.58 | -18.58 | -25.46 | -23.90 | -24.57 | -22.40 | -41.31 | -53.34 | -52.69 | -36.37 | -66.74 | -52.48 | -44.90 | -37.62 | -30.19 | -52.21 | -78.45 | -98.40 | -87.96 | -78.11 | -70.93 | -62.47 | -58.28 | -50.03 | -39.50 | -30.65 | -32.86 | -29.86 | -28.56 | -22.50 | -11.99 | -6.41 | -0.26 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-186.36 | -193.57 | -178.99 | -186.34 | -273.55 | -319.14 | -287.34 | -120.92 | -129.71 | -51.28 | -42.67 | -19.28 | -27.22 | -26.37 | -28.15 | -27.21 | -62.75 | -90.35 | -90.39 | -58.64 | 100.36 | 160.56 | 71.11 | -3.63 | 116.39 | 59.40 | 126.97 | 187.52 | -104.96 | -90.73 | -79.57 | -67.24 | -62.64 | -53.40 | -34.06 | -8.86 | -8.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.1 | 3.0 | 4.0 | 5.1 | 3.6 | 3.3 | 2.2 | 3.4 | 6.3 | - | 17.0 | 19.3 | 27.4 | 30.5 | 25.5 | 9.0 | 9.0 | 9.0 | 9.0 | 4.2 | 4.2 | 4.2 | 4.2 | 0.8 | 0.8 | 9.4 | 9.4 | 5.9 | 5.9 | 5.9 | 5.9 | 16.2 | 16.2 | 16.2 | 16.2 | 33.0 | 33.0 | 33.0 | 33.0 | 31.8 | 31.8 | 31.8 | 31.8 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | 720.1 | 292.1 | - | 255.3 | 283.0 | 155.3 | - | - | - | 34.3 | 113.9 | 62.0 | 24.0 | 15.6 | 14.7 | 12.2 | 13.1 | 13.2 | 13.2 | 11.4 | 10.3 | 5.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 373.0 | 338.9 | 249.9 | 247.7 | 117.3 | 336.4 | 295.6 | 264.9 | 271.2 | 511.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4521.0 | 2092.6 | 458.9 | 355.5 | 173.7 | 1275.8 | 1371.7 | 1229.6 | 1258.6 | 1843.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | 720.1 | 292.1 | - | 255.3 | 283.0 | 155.3 | - | - | 373.0 | 373.2 | 363.8 | 309.7 | 141.3 | 351.9 | 310.3 | 277.2 | 284.3 | 524.2 | 13.2 | 11.4 | 10.3 | 5.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | 720.1 | 292.1 | - | 255.3 | 283.0 | 155.3 | - | - | -4148.0 | -1719.4 | -95.1 | -45.8 | -32.4 | -923.8 | -1061.4 | -952.4 | -974.3 | -1319.4 | 13.2 | 11.4 | 10.3 | 5.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency